RNS Number:3346R
BioProgress PLC
27 October 2003


                BioProgress PLC ("BioProgress" or the "Company")

Pursuant to the exercise of an option by Collins Stewart Limited over 1,500,000
ordinary shares of 1p each in the Company, application has been made for these
new ordinary shares ("New Shares") to be admitted to the Alternative Investment
Market ("AIM"). The option exercise price is 16 pence per share.

Admission of the New Shares is expected to become effective on 29 October 2003.

27 October 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
MSCBBBDGSUDGGXR